235 related articles for article (PubMed ID: 34108036)
41. Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB).
Malhotra A; Nonyane BAS; Shirey E; Mulder C; Hippner P; Mulatu F; Ratshinanga A; Mitiku P; Cohn S; Conradie G; Chihota V; Chaisson RE; Churchyard GJ; Golub J; Dowdy D; Sohn H; Charalambous S; Bedru A; Salazar-Austin N
Trials; 2023 Jul; 24(1):475. PubMed ID: 37491264
[TBL] [Abstract][Full Text] [Related]
42. Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial.
Kamal AK; Muqeet A; Farhat K; Khalid W; Jamil A; Gowani A; Muhammad AA; Zaidi F; Khan D; Elahi T; Sharif S; Raz S; Zafar T; Bokhari SS; Rahman N; Sultan FA; Sayani S; Virani SS
Trials; 2016 Mar; 17(1):121. PubMed ID: 26944938
[TBL] [Abstract][Full Text] [Related]
43. Screening and brief interventions for hazardous and harmful alcohol use among patients with active tuberculosis attending primary public care clinics in South Africa: results from a cluster randomized controlled trial.
Peltzer K; Naidoo P; Louw J; Matseke G; Zuma K; McHunu G; Tutshana B; Mabaso M
BMC Public Health; 2013 Jul; 13():699. PubMed ID: 23902931
[TBL] [Abstract][Full Text] [Related]
44. Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study.
Drabarek D; Anh NT; Nhung NV; Hoa NB; Fox GJ; Bernays S
PLoS One; 2019; 14(7):e0219891. PubMed ID: 31329610
[TBL] [Abstract][Full Text] [Related]
45. A randomised controlled trial to evaluate a medication monitoring system for TB treatment.
Acosta J; Flores P; Alarcón M; Grande-Ortiz M; Moreno-Exebio L; Puyen ZM
Int J Tuberc Lung Dis; 2022 Jan; 26(1):44-49. PubMed ID: 34969428
[TBL] [Abstract][Full Text] [Related]
46. Combined effect of pill refilling and self-medication reminder system on patients' adherence to tuberculosis treatment during continuation phase in Northwest Ethiopia: a study protocol for randomised controlled trial.
Gashu KD; Gelaye KA; Lester R; Tilahun B
BMJ Health Care Inform; 2019 Aug; 26(1):. PubMed ID: 31484661
[TBL] [Abstract][Full Text] [Related]
47. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
Tadesse AW; Mganga A; Dube TN; Alacapa J; van Kalmthout K; Letta T; Mleoh L; Garfin AMC; Maraba N; Charalambous S; Foster N; Jerene D; Fielding KL
Front Public Health; 2024; 12():1327971. PubMed ID: 38444445
[TBL] [Abstract][Full Text] [Related]
48. Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
Martinson NA; Nonyane BAS; Genade LP; Berhanu RH; Naidoo P; Brey Z; Kinghorn A; Nyathi S; Young K; Hausler H; Connell L; Lutchminarain K; Swe Swe-Han K; Vreede H; Said M; von Knorring N; Moulton LH; Lebina L;
PLoS Med; 2023 May; 20(5):e1004237. PubMed ID: 37216385
[TBL] [Abstract][Full Text] [Related]
49. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
[TBL] [Abstract][Full Text] [Related]
50. Intensified household contact tracing, prevention and treatment support versus enhanced standard of care for contacts of tuberculosis cases in South Africa: study protocol for a household cluster-randomised trial.
MacPherson P; Webb EL; Variava E; Lala SG; Milovanovic M; Ratsela A; Lebina L; Kinghorn A; Martinson NA
BMC Infect Dis; 2019 Oct; 19(1):839. PubMed ID: 31606032
[TBL] [Abstract][Full Text] [Related]
51. Impact of community tracer teams on treatment outcomes among tuberculosis patients in South Africa.
Bronner LE; Podewils LJ; Peters A; Somnath P; Nshuti L; van der Walt M; Mametja LD
BMC Public Health; 2012 Aug; 12():621. PubMed ID: 22871071
[TBL] [Abstract][Full Text] [Related]
52. A cluster randomized controlled trial of extending ART refill intervals to six-monthly for anti-retroviral adherence clubs.
Wilkinson L; Grimsrud A; Cassidy T; Orrell C; Voget J; Hayes H; Keene C; Steele SJ; Gerstenhaber R
BMC Infect Dis; 2019 Jul; 19(1):674. PubMed ID: 31362715
[TBL] [Abstract][Full Text] [Related]
53. Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion.
Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger CA; Tucker A; Patel D; Sammann A; Dowdy D; Stavia T; Cattamanchi A; Katamba A
BMJ Open; 2020 Nov; 10(11):e039895. PubMed ID: 33247012
[TBL] [Abstract][Full Text] [Related]
54. Effect of a phone reminder system on patient-centered tuberculosis treatment adherence among adults in Northwest Ethiopia: a randomised controlled trial.
Gashu KD; Gelaye KA; Lester R; Tilahun B
BMJ Health Care Inform; 2021 Jun; 28(1):. PubMed ID: 34172505
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for poor engagement with a smart pillbox adherence intervention among persons on tuberculosis treatment in Ethiopia.
Tadesse AW; Cusinato M; Weldemichael GT; Abdurhman T; Assefa D; Yazew H; Gadissa D; Shiferaw A; Belachew M; Sahile M; van Rest J; Bedru A; Foster N; Jerene D; Fielding KL
BMC Public Health; 2023 Oct; 23(1):2006. PubMed ID: 37838677
[TBL] [Abstract][Full Text] [Related]
56. Staff training and ambulatory tuberculosis treatment outcomes: a cluster randomized controlled trial in South Africa.
Lewin S; Dick J; Zwarenstein M; Lombard CJ
Bull World Health Organ; 2005 Apr; 83(4):250-9. PubMed ID: 15868015
[TBL] [Abstract][Full Text] [Related]
57. Perceptions and acceptability of short message services technology to improve treatment adherence amongst tuberculosis patients in Peru: a Focus Group Study.
Albino S; Tabb KM; Requena D; Egoavil M; Pineros-Leano MF; Zunt JR; García PJ
PLoS One; 2014; 9(5):e95770. PubMed ID: 24828031
[TBL] [Abstract][Full Text] [Related]
58. Randomised controlled trial of a video intervention and behaviour contract to improve medication adherence after renal transplantation: the VECTOR study protocol.
Mansell H; Rosaasen N; West-Thielke P; Wichart J; Daley C; Mainra R; Shoker A; Liu J; Blackburn D
BMJ Open; 2019 Mar; 9(3):e025495. PubMed ID: 30872550
[TBL] [Abstract][Full Text] [Related]
59. Improving medication adherence among persons with cardiovascular disease through m-health and community health worker-led interventions in Kerala; protocol for a type II effectiveness-implementation research-(SHRADDHA-ENDIRA).
Menon JC; John D; Sreedevi A; Janakiram C; R A; S S; M S A; Numpeli M; Gopal B; B A R; P K S; Lakshmanaswamy R; Kunwar A
Trials; 2024 Jul; 25(1):437. PubMed ID: 38956612
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
